nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfanilamide—CA7—colon cancer	0.88	1	CbGaD
Sulfanilamide—CA6—Reversible hydration of carbon dioxide—CA7—colon cancer	0.021	0.255	CbGpPWpGaD
Sulfanilamide—CA12—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0182	0.221	CbGpPWpGaD
Sulfanilamide—CA2—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0139	0.169	CbGpPWpGaD
Sulfanilamide—CA9—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0117	0.142	CbGpPWpGaD
Sulfanilamide—CYP2C9—Capecitabine—colon cancer	0.00805	0.441	CbGbCtD
Sulfanilamide—CYP2C9—Fluorouracil—colon cancer	0.00477	0.262	CbGbCtD
Sulfanilamide—Mafenide—CA7—colon cancer	0.0041	0.873	CrCbGaD
Sulfanilamide—CYP3A4—Irinotecan—colon cancer	0.00289	0.158	CbGbCtD
Sulfanilamide—CYP3A4—Vincristine—colon cancer	0.00253	0.139	CbGbCtD
Sulfanilamide—CA9—gall bladder—colon cancer	0.00211	0.15	CbGeAlD
Sulfanilamide—CA7—renal system—colon cancer	0.00115	0.0817	CbGeAlD
Sulfanilamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—colon cancer	0.00107	0.013	CbGpPWpGaD
Sulfanilamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—colon cancer	0.00102	0.0124	CbGpPWpGaD
Sulfanilamide—CA7—digestive system—colon cancer	0.000946	0.0671	CbGeAlD
Sulfanilamide—CA9—digestive system—colon cancer	0.000831	0.0589	CbGeAlD
Sulfanilamide—CA2—gall bladder—colon cancer	0.000801	0.0568	CbGeAlD
Sulfanilamide—CA9—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.000768	0.00933	CbGpPWpGaD
Sulfanilamide—CA12—renal system—colon cancer	0.000749	0.0531	CbGeAlD
Sulfanilamide—CYP2D6—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000667	0.00811	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metapathway biotransformation—CHST4—colon cancer	0.000657	0.00798	CbGpPWpGaD
Sulfanilamide—CA12—digestive system—colon cancer	0.000614	0.0436	CbGeAlD
Sulfanilamide—CA2—embryo—colon cancer	0.000508	0.036	CbGeAlD
Sulfanilamide—CYP2C19—Metapathway biotransformation—CHST4—colon cancer	0.000507	0.00616	CbGpPWpGaD
Sulfanilamide—CA9—HIF-1-alpha transcription factor network—ABCB1—colon cancer	0.000479	0.00582	CbGpPWpGaD
Sulfanilamide—CA9—Cellular response to hypoxia—EP300—colon cancer	0.000474	0.00576	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metapathway biotransformation—CHST4—colon cancer	0.000466	0.00566	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metapathway biotransformation—CHST4—colon cancer	0.000462	0.00561	CbGpPWpGaD
Sulfanilamide—CA9—Cellular response to hypoxia—VEGFA—colon cancer	0.000449	0.00546	CbGpPWpGaD
Sulfanilamide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000436	0.0053	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—CA7—colon cancer	0.000427	0.00518	CbGpPWpGaD
Sulfanilamide—CA2—epithelium—colon cancer	0.000415	0.0294	CbGeAlD
Sulfanilamide—CA2—smooth muscle tissue—colon cancer	0.000399	0.0283	CbGeAlD
Sulfanilamide—CA2—renal system—colon cancer	0.000385	0.0273	CbGeAlD
Sulfanilamide—CA12—Metabolism—CA7—colon cancer	0.000369	0.00448	CbGpPWpGaD
Sulfanilamide—CYP2C19—digestive system—colon cancer	0.000344	0.0244	CbGeAlD
Sulfanilamide—CA2—lymphoid tissue—colon cancer	0.000319	0.0226	CbGeAlD
Sulfanilamide—CA2—digestive system—colon cancer	0.000315	0.0224	CbGeAlD
Sulfanilamide—CYP2E1—renal system—colon cancer	0.000308	0.0219	CbGeAlD
Sulfanilamide—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000305	0.0037	CbGpPWpGaD
Sulfanilamide—CYP2C19—vagina—colon cancer	0.000304	0.0216	CbGeAlD
Sulfanilamide—CYP2E1—Metapathway biotransformation—CHST5—colon cancer	0.000302	0.00366	CbGpPWpGaD
Sulfanilamide—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000296	0.00359	CbGpPWpGaD
Sulfanilamide—CA2—bone marrow—colon cancer	0.000291	0.0206	CbGeAlD
Sulfanilamide—CA2—Metabolism—CA7—colon cancer	0.000282	0.00343	CbGpPWpGaD
Sulfanilamide—CA2—vagina—colon cancer	0.000279	0.0197	CbGeAlD
Sulfanilamide—CYP2C9—digestive system—colon cancer	0.000267	0.0189	CbGeAlD
Sulfanilamide—CA6—Metabolism—ODC1—colon cancer	0.000259	0.00314	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—CHST5—colon cancer	0.000259	0.00314	CbGpPWpGaD
Sulfanilamide—CYP2C19—liver—colon cancer	0.000256	0.0182	CbGeAlD
Sulfanilamide—CYP2E1—lymphoid tissue—colon cancer	0.000256	0.0182	CbGeAlD
Sulfanilamide—CYP2E1—digestive system—colon cancer	0.000253	0.0179	CbGeAlD
Sulfanilamide—CYP3A4—renal system—colon cancer	0.000248	0.0176	CbGeAlD
Sulfanilamide—CYP2D6—renal system—colon cancer	0.000244	0.0173	CbGeAlD
Sulfanilamide—CA7—Metabolism—CHST5—colon cancer	0.000241	0.00293	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—ODC1—colon cancer	0.000241	0.00293	CbGpPWpGaD
Sulfanilamide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000239	0.00291	CbGpPWpGaD
Sulfanilamide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000239	0.0029	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—CA7—colon cancer	0.000238	0.00289	CbGpPWpGaD
Sulfanilamide—CA2—liver—colon cancer	0.000235	0.0167	CbGeAlD
Sulfanilamide—CYP2C19—Metapathway biotransformation—CHST5—colon cancer	0.000233	0.00283	CbGpPWpGaD
Sulfanilamide—Benzocaine—ABCB1—colon cancer	0.000228	0.0485	CrCbGaD
Sulfanilamide—CA12—Metabolism—CHST5—colon cancer	0.000224	0.00272	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—ODC1—colon cancer	0.000224	0.00272	CbGpPWpGaD
Sulfanilamide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000218	0.00265	CbGpPWpGaD
Sulfanilamide—CA9—HIF-1-alpha transcription factor network—EP300—colon cancer	0.000218	0.00265	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metapathway biotransformation—CHST5—colon cancer	0.000214	0.0026	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	0.000212	0.00258	CbGpPWpGaD
Sulfanilamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000208	0.00253	CbGpPWpGaD
Sulfanilamide—CA9—HIF-1-alpha transcription factor network—VEGFA—colon cancer	0.000207	0.00251	CbGpPWpGaD
Sulfanilamide—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000206	0.0025	CbGpPWpGaD
Sulfanilamide—CYP3A4—digestive system—colon cancer	0.000203	0.0144	CbGeAlD
Sulfanilamide—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000201	0.00244	CbGpPWpGaD
Sulfanilamide—CYP2D6—digestive system—colon cancer	0.0002	0.0142	CbGeAlD
Sulfanilamide—CYP2C9—liver—colon cancer	0.000199	0.0141	CbGeAlD
Sulfanilamide—Aminohippurate—ABCB1—colon cancer	0.00019	0.0406	CrCbGaD
Sulfanilamide—CYP2E1—liver—colon cancer	0.000188	0.0134	CbGeAlD
Sulfanilamide—CA2—lymph node—colon cancer	0.00018	0.0128	CbGeAlD
Sulfanilamide—Dapsone—PTGS2—colon cancer	0.000178	0.0379	CrCbGaD
Sulfanilamide—CA2—Metabolism—ODC1—colon cancer	0.000171	0.00208	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—CHST5—colon cancer	0.000171	0.00208	CbGpPWpGaD
Sulfanilamide—CYP3A4—liver—colon cancer	0.000152	0.0107	CbGeAlD
Sulfanilamide—CYP2D6—liver—colon cancer	0.000149	0.0106	CbGeAlD
Sulfanilamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000145	0.00176	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—CHST5—colon cancer	0.000144	0.00175	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—ODC1—colon cancer	0.000144	0.00175	CbGpPWpGaD
Sulfanilamide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000144	0.00175	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.00014	0.0017	CbGpPWpGaD
Sulfanilamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000137	0.00167	CbGpPWpGaD
Sulfanilamide—CA9—HIF-1-alpha transcription factor network—AKT1—colon cancer	0.000132	0.0016	CbGpPWpGaD
Sulfanilamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	9.54e-05	0.00116	CbGpPWpGaD
Sulfanilamide—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	9.17e-05	0.00111	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CA7—colon cancer	8.63e-05	0.00105	CbGpPWpGaD
Sulfanilamide—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	8.36e-05	0.00102	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—CDKN1A—colon cancer	7.56e-05	0.000918	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—EP300—colon cancer	7.19e-05	0.000874	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—ABCB1—colon cancer	6.83e-05	0.00083	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—VEGFA—colon cancer	6.81e-05	0.000828	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—TYMS—colon cancer	6.71e-05	0.000815	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CA7—colon cancer	6.66e-05	0.000809	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—ABCB1—colon cancer	6.38e-05	0.000775	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—TYMS—colon cancer	6.26e-05	0.000761	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CA7—colon cancer	6.12e-05	0.000744	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CA7—colon cancer	6.07e-05	0.000738	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—ABCB1—colon cancer	5.91e-05	0.000718	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—TYMS—colon cancer	5.8e-05	0.000705	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CHST5—colon cancer	5.23e-05	0.000635	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ODC1—colon cancer	5.23e-05	0.000635	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—TP53—colon cancer	5.15e-05	0.000625	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—PPARG—colon cancer	4.75e-05	0.000577	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—ABCB1—colon cancer	4.52e-05	0.000549	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—PPARG—colon cancer	4.44e-05	0.000539	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—TYMS—colon cancer	4.44e-05	0.000539	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—PPARG—colon cancer	4.11e-05	0.000499	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ODC1—colon cancer	4.03e-05	0.00049	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CHST5—colon cancer	4.03e-05	0.00049	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CA7—colon cancer	4e-05	0.000486	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—ABCB1—colon cancer	3.81e-05	0.000463	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—TYMS—colon cancer	3.74e-05	0.000454	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—PTGS2—colon cancer	3.74e-05	0.000454	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CHST5—colon cancer	3.71e-05	0.000451	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ODC1—colon cancer	3.71e-05	0.000451	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CHST5—colon cancer	3.68e-05	0.000447	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ODC1—colon cancer	3.68e-05	0.000447	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—PTGS2—colon cancer	3.49e-05	0.000424	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—PTGS2—colon cancer	3.23e-05	0.000393	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—PPARG—colon cancer	3.14e-05	0.000382	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—EP300—colon cancer	3.11e-05	0.000378	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—EP300—colon cancer	2.9e-05	0.000353	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—EP300—colon cancer	2.69e-05	0.000327	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—PPARG—colon cancer	2.65e-05	0.000322	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—PTGS2—colon cancer	2.47e-05	0.0003	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ODC1—colon cancer	2.43e-05	0.000295	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—CHST5—colon cancer	2.43e-05	0.000295	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—PIK3CA—colon cancer	2.3e-05	0.000279	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—PIK3CA—colon cancer	2.15e-05	0.000261	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—PTGS2—colon cancer	2.08e-05	0.000253	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—EP300—colon cancer	2.06e-05	0.00025	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—PIK3CA—colon cancer	1.99e-05	0.000242	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—AKT1—colon cancer	1.88e-05	0.000228	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—AKT1—colon cancer	1.75e-05	0.000213	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—EP300—colon cancer	1.73e-05	0.000211	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.67e-05	0.000202	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—AKT1—colon cancer	1.63e-05	0.000197	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—PIK3CA—colon cancer	1.52e-05	0.000185	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.52e-05	0.000184	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ABCB1—colon cancer	1.38e-05	0.000168	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—TYMS—colon cancer	1.36e-05	0.000165	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.31e-05	0.000159	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—PIK3CA—colon cancer	1.28e-05	0.000156	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—AKT1—colon cancer	1.24e-05	0.000151	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.19e-05	0.000145	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.09e-05	0.000132	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ABCB1—colon cancer	1.07e-05	0.000129	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—AKT1—colon cancer	1.05e-05	0.000127	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—TYMS—colon cancer	1.05e-05	0.000127	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.93e-06	0.000121	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ABCB1—colon cancer	9.8e-06	0.000119	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ABCB1—colon cancer	9.72e-06	0.000118	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—TYMS—colon cancer	9.63e-06	0.000117	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PPARG—colon cancer	9.61e-06	0.000117	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—TYMS—colon cancer	9.55e-06	0.000116	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.06e-06	9.79e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PTGS2—colon cancer	7.56e-06	9.19e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PPARG—colon cancer	7.42e-06	9.01e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.35e-06	8.93e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PPARG—colon cancer	6.82e-06	8.29e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PPARG—colon cancer	6.76e-06	8.21e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ABCB1—colon cancer	6.41e-06	7.79e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—TYMS—colon cancer	6.3e-06	7.65e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—EP300—colon cancer	6.29e-06	7.64e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PTGS2—colon cancer	5.83e-06	7.09e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PTGS2—colon cancer	5.37e-06	6.52e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PTGS2—colon cancer	5.32e-06	6.46e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—EP300—colon cancer	4.85e-06	5.89e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PIK3CA—colon cancer	4.65e-06	5.65e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—EP300—colon cancer	4.46e-06	5.42e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PPARG—colon cancer	4.46e-06	5.42e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—EP300—colon cancer	4.42e-06	5.37e-05	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—AKT1—colon cancer	3.8e-06	4.62e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PIK3CA—colon cancer	3.59e-06	4.36e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PTGS2—colon cancer	3.51e-06	4.26e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PIK3CA—colon cancer	3.3e-06	4.01e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PIK3CA—colon cancer	3.27e-06	3.98e-05	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—AKT1—colon cancer	2.93e-06	3.56e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—EP300—colon cancer	2.92e-06	3.54e-05	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—AKT1—colon cancer	2.7e-06	3.28e-05	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—AKT1—colon cancer	2.67e-06	3.25e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PIK3CA—colon cancer	2.16e-06	2.62e-05	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—AKT1—colon cancer	1.76e-06	2.14e-05	CbGpPWpGaD
